Marine invader under monitoring
18 May, 2005Scientists have developed a genetic tool to help environmental authorities monitor the spread and impact of Australia's most invasive marine species, the New Zealand screwshell.
Animal-friendly herbicide in development
13 May, 2005Scientists at Monash University are researching an environmentally friendly alternative to herbicides that targets weeds but does not affect animals. This research could also lead to new treatments for the internationally alarming health issue of tuberculosis infection.
Mouse models
13 May, 2005 | Supplied by: http://www.artisoptimus.com/ArtisOptimus and Taconic Farms are jointly using their strengths in MEF production and patented mouse models to bring a collection of primary mouse embryonic fi-broblasts to the research com-munity, under the brand name OptiMEF.
Screening drugs of abuse by LC/MS
08 May, 2005 | Supplied by: Keysight Technologies Australia Pty LtdHigh throughput screening of drugs of abuse is performed at St Olav Hospital by LC/MS. Typically done by immunoassay, this overview describes the procedures for using this highly selective and quantitative LC/MS methodology
Non-viral vectors deliver genes
05 May, 2005A gene therapy method that doesn't rely on potentially toxic viruses as vectors may be growing closer as the result of in vitro research results reported by University at Buffalo scientists in the current online issue of the Proceedings of the National Academy of Sciences.
Research aids coughing
13 April, 2005UTS Professor Ashley Craig is involved in a project in the NSW Premier's spinal chord injury (SCI) research program to develop an electrical stimulus to help quadriplegics cough.
Keeping frog disease under control
11 April, 2005A workshop on new methods of detecting and controlling the spread of one of the world's most deadly frog diseases – chytridiomycosis – was recently held at CSIRO Livestock Industries' Australian Animal Health Laboratory (AAHL) in Geelong, Victoria.
Gene revolution in India
28 February, 2005It’s the news they have all been waiting for. After years of living under the threat of another devastating epidemic of downy mildew, a disease similar to that which caused the Irish potato famine, India’s poorest farmers have been offered a lifeline in the form of a new disease-resistant hybrid. The hybrid has been produced in record time using modern biotechnology techniques.
Cell processing facility contracted for clinical trials
16 February, 2005Australia’s adult stem cell company, Mesoblast has signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
Why does cloning create abnormalities?
20 September, 2004Significant abnormalities observed in cloned mice help reinforce the need to continue to avoid the reproductive cloning of humans, claims Dr Takumi Takeuchi, from Cornell University.
Super ants threaten to take over Melbourne
03 September, 2004A giant supercolony of Argentine Ants stretching across the Greater City of Melbourne has been discovered by Ms Elissa Suhr from the School of Biological Sciences at Monash University.
Bird flu vaccine on way
27 August, 2004CSIRO Livestock Industries has developed an experimental vaccine to protect chickens from the deadly H5N1 strain of avian influenza (bird flu).
Duo fears for DNA privacy
11 August, 2004Two Monash law academics are calling for urgent state government action following the disclosure that a private Melbourne company holds the DNA records of millions of Victorians.
Glaciers contribute to climate change
11 August, 2004The response of the world’s glaciers to global warming is an important element in understanding climate change, involving sea-level change and changes to the circulation in the North Atlantic. To predict changes, scientists believe it is vital to understand the behaviour of glaciers.
Flies uncovered
10 August, 2004Australia will have a much greater capacity to understand its fly biodiversity with a generous endowment from an American benefactor.
